Fight CRC and Cancer Research Institute Award $400,000 to Support Cutting-Edge Immunotherapy Research in Colorectal Cancer
$400k grant to Johns Hopkins University School of Medicine investigator Cynthia Sears will carry out research aimed at improving effectiveness of immunotherapy in patients with colorectal cancer.
28-Jun-2017 10:00 AM EDT Add to Favorites
Cancer Research Institute Awards $1 Million to Fund the Development of Innovative Microchip-Based Research Models of Organ-Specific Cancer Immunotherapy
$1 million CRI Technology Impact Award will support UPENN investigator's development of microchip-based research models that mimic human cancer and immune cell interactions
26-Jun-2017 12:00 PM EDT Add to Favorites
Cancer Patients and Caregivers Join Immunotherapy Experts in Five U.S. Cities to Discuss Latest Cancer Treatment Breakthroughs and Immunotherapy Clinical Trials
CRI's 2017 Immunotherapy Patient Summit Series will travel to five U.S. cities to provide free educational programming designed for cancer patients and caregivers who are seeking to learn more about cancer immunotherapy and clinical trials.
20-Jun-2017 12:05 PM EDT Add to Favorites
Cancer Research Institute to Bring Together Cancer Patients, Leading Immunotherapy Manufacturers, and Highland Falls Community Members for Second Annual Answer to Cancer Sponsored by Bristol-Myers Squibb
Day-long endurance event starting at the U.S. Military Academy at West Point, NY, focused on cancer immunotherapy research
7-Jun-2017 5:00 AM EDT Add to Favorites
Cancer Research Institute Hosts Fifth Annual Cancer Immunotherapy Month™ in June to Celebrate Progress in Cancer Research and Patient Treatment
Cancer Immunotherapy Month in June to feature educational and awareness programming for patients, caregivers, and the public
1-Jun-2017 5:00 AM EDT Add to Favorites
Immunotherapy Data from the Cancer Research Institute Clinical Accelerator to Be Presented at ASCO Annual Meeting
data from four early-phase immunotherapy combination trials will be presented at the American Society for Clinical Oncology (ASCO) Annual meeting in Chicago on June 5, 2017.
23-May-2017 8:00 AM EDT Add to Favorites
Cancer Research Institute Appoints Dr. Aiman Shalabi as Chief Medical Officer to Accelerate Precision Immunotherapy Clinical Collaborations
Nonprofit cancer immunotherapy research organization hires pharmaceutical executive to lead its clinical trials program
17-Apr-2017 8:00 AM EDT Add to Favorites
Over the past few years, checkpoint blockade immunotherapies have revolutionized cancer treatment and helped many patients who were previously considered untreatable. Now, discoveries made by two Cancer Research Institute scientists could help make...
7-Mar-2017 2:05 PM EST Add to Favorites
The FDA announced on Aug 4 2009 that tumor necrosis factor (TNF) blockers used in the treatment of immune disorders carry an increased risk of lymphoma and other cancers in children and adolescents. The discoverer of TNF-alpha, Lloyd J. Old, M.D., a...
7-Aug-2009 9:00 AM EDT
Dendreon's PROVENGE for the treatment of advanced prostate cancer is the first active cellular immunotherapy to prolong patient survival, according to data from a pivotal phase III clinical trial announced at yesterday's AUA annual meeting in...
29-Apr-2009 11:20 AM EDT